Iris Melanoma — Trials

Iris Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02068586	Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma	active not recruiting	Phase 2	210	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	Mar 16, 2026	clinicaltrials

Data updated 22 days agoSource updated Mar 16, 2026source: clinicaltrials